Moreover, it is well documented that almost all CAN-genes in core modules from gliomas exhibit critical alterations in the three important pathway, TP53 pathway (TP53), RB1 pathway (RB1 and CDKN2A), and PI3K/PTEN pathway (PIK3R1, PTEN) [17]. This evidence concerns the gene CDKN2A and central nervous system cancer.